DrugPatentWatch Database Preview
Details for Patent: 7,687,516
Which drugs does patent 7,687,516 protect, and when does it expire?
Patent 7,687,516 protects ARGATROBAN IN SODIUM CHLORIDE and is included in one NDA.
This patent has seven patent family members in five countries.
This patent has seven patent family members in five countries.
Summary for Patent: 7,687,516
| Title: | Alcohol free formulation of argatroban |
| Abstract: | An aqueous formulation of argatroban and of related compounds is disclosed along with a reconstitutable formulation, each of which is substantially, if not totally alcohol free. The formulations are also substantially free, if not totally free, of mono-, di-, and oligo-saccharides. An especially preferred embodiment is a ready-to-administer 1 mg/ml injectable dosage form having argatroban, lactobionic acid, and methionine. |
| Inventor(s): | Palepu; Nageswara R. (Southampton, PA) |
| Assignee: | Eagle Pharmaceuticals, Inc. (Woodcliff Lake, NJ) |
| Application Number: | 11/973,485 |
|
Patent Claim Types: see list of patent claims | Formulation; Compound; Use; Composition; |
Drugs Protected by US Patent 7,687,516
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Patent Submitted |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Eagle Pharms | ARGATROBAN IN SODIUM CHLORIDE | argatroban | INJECTABLE;IV (INFUSION) | 022434-001 | Jun 29, 2011 | RX | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | Y | METHOD OF TREATING AN ARGATROBAN TREATABLE CONDITION | ➤ Try a Free Trial | |||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Patent Submitted |
Non-Orange Book US Patents Family Members for Patent 7,687,516
For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.
The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.
| Patent No. | Title | Estimated Patent Expiration |
|---|---|---|
| 7,589,106 | Alcohol free formulation of argatroban | ➤ Try a Free Trial |
| Patent No. | Title | Estimated Patent Expiration |
International Family Members for US Patent 7,687,516
| Country | Document Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Canada | 2669727 | ➤ Try a Free Trial | |||
| China | 101516370 | ➤ Try a Free Trial | |||
| European Patent Office | 2083823 | ➤ Try a Free Trial | |||
| Japan | 2010504971 | ➤ Try a Free Trial | |||
| Country | Document Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
